NCT03742466View on ClinicalTrials.gov

Local Injection of Ozone Versus Methylprednisolone Acetate in Carpal Tunnel Syndrome of Scleroderma Patients

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 10, 2018

Primary Completion Date

July 30, 2019

Study Completion Date

September 30, 2019

Conditions
Carpal Tunnel SyndromeChronic PainScleroderma
Interventions
DRUG

Ozone

After prepping and draping the area, intracarpal injection of ozone/oxygen mixture (20 ml, 25μg/ml) will be performed under sonographic guidance

DRUG

methylprednisolone acetate

After prepping and draping the area, intracarpal injection of methylprednisolone acetate 40mg, and 40 mg lidocaine (20 ml, volume) will be performed under sonographic guidance

Trial Locations (1)

71111

Emad Zarief Kamel Said, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03742466 - Local Injection of Ozone Versus Methylprednisolone Acetate in Carpal Tunnel Syndrome of Scleroderma Patients | Biotech Hunter | Biotech Hunter